Journal Logo

You can read the full text of this article if you:

Access through Ovid
PAPERS OF THE 141ST ASA ANNUAL MEETING

Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy

Modlin, Irvin M. MD, PhD, DSc, FRCS; Kidd, Mark PhD; Frilling, Andrea MD, FACS; Falconi, Massimo MD§; Filosso, Pier Luigi MD; Malczewska, Anna MD, PhD||; Kitz, Alexandra PhD

Author Information
doi: 10.1097/SLA.0000000000005026
  • Buy
  • SDC

Abstract

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.